Compound Detail
CHEMBL154745
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL154745 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | OMKHWTRUYNAGFG-IEBDPFPHSA-N |
12
Targets
17
Activities
2
Assay Types
1
PK Parameters
20
Publications
0
Known Names
Molecular Properties
262.3
MW (Da)
-0.79
ALogP
7
HBA
4
HBD
117.4
PSA (Ų)
0.53
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 16 meas. best 8.5
Ki 1 meas. best 11.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Adenosylhomocysteinase CHEMBL2664 | Ki | 11.0 | 11.0 | 0.0 | 1 |
| AdoHcyase_NAD domain-containing protein CHEMBL4295548 | IC50 | 8.5 | 8.5 | 3.2 | 1 |
| Unchecked CHEMBL612545 | IC50 | 8.03 | 8.03 | 9.3 | 1 |
| Histone-lysine N-methyltransferase EZH2 CHEMBL2189110 | IC50 | 7.1 | 7.1 | 80.0 | 1 |
| NCI-H1975 CHEMBL614348 | IC50 | 7.1 | 7.1 | 80.0 | 1 |
| PC-3 CHEMBL390 | IC50 | 6.72 | 5.875 | 190.0 | 2 |
| NCI-H1299 CHEMBL612255 | IC50 | 6.68 | 6.68 | 210.0 | 1 |
| A549 CHEMBL392 | IC50 | 6.62 | 6.235 | 240.0 | 2 |
| HCT-116 CHEMBL394 | IC50 | 6.58 | 6.58 | 260.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
| Adenosylhomocysteinase CHEMBL2664 | IC50 | 6.36 | 6.36 | 440.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 6.14 | 6.09 | 720.0 | 2 |
| SARS-CoV-2 CHEMBL4303835 | IC50 | 5.68 | 5.68 | 2070.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| T1/2 | 1.1 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 25203626 | 10.1097/cad.0000000000000166 | MDA-MB-231 | 8 |
| - | 10.1039/C6MD00170J | MCF7 | 8 |
| 25203626 | 10.1097/cad.0000000000000166 | HepG2 | 6 |
| 27226494 | 10.1093/nar/gkw463 | Histone-lysine N-methyltransferase EZH2 | 5 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| - | 10.1039/C6MD00170J | NON-PROTEIN TARGET | 4 |
| - | 10.1016/S0960-894X(01)80163-3 | Vero | 3 |
| 25203626 | 10.1097/cad.0000000000000166 | Histone-lysine N-methyltransferase EZH2 | 3 |
| - | 10.1039/C6MD00170J | Histone-lysine N-methyltransferase EHMT2 | 2 |
| 27226494 | 10.1093/nar/gkw463 | Unchecked | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4495565 | ADMET | 2 |
| - | 10.6019/CHEMBL4495565 | Vero C1008 | 2 |
| 26010585 | 10.1021/acs.jmedchem.5b00553 | NON-PROTEIN TARGET | 2 |
| 25203626 | 10.1097/cad.0000000000000166 | A549 | 2 |
| 30809307 | 10.7150/thno.29520 | MCF7 | 1 |
| - | 10.1039/C6MD00170J | Unchecked | 1 |
| 26010585 | 10.1021/acs.jmedchem.5b00553 | PC-3 | 1 |
| 26010585 | 10.1021/acs.jmedchem.5b00553 | HCT-116 | 1 |
| 26010585 | 10.1021/acs.jmedchem.5b00553 | A549 | 1 |
Data from ChEMBL 36 via Core Engine